GATA2 methylation and FGFR3 mutation predict progression in BCG-treated high-risk non-muscle-invasive bladder cancer

Saved in:
Bibliographic Details
Published in:European urology 2023-02, Vol.83, p.S405-S406
Main Authors: Olislagers, M., De Jong, F.C., Van Etten, V.M.J., Kan, T.W., Zuiverloon, T.C.M.
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0302-2838
DOI:10.1016/S0302-2838(23)00330-5